Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).

Schuh A. et al, (2023), Br J Ophthalmol

Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.

Cuppen E. et al, (2022), JCO Precis Oncol, 6

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Robbe P. et al, (2022), Nat Genet

A rare HIV-associated hyaline vascular multicentric castleman disease with good early response to single-agent rituximab: A case from Tanzania

Mawalla WF. et al, (2022), Human Pathology Reports, 30

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Alaggio R. et al, (2022), Leukemia

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Khoury JD. et al, (2022), Leukemia

Guideline for the treatment of chronic lymphocytic leukaemia.

Walewska R. et al, (2022), Br J Haematol, 197, 544 - 557

Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.

Reijns MAM. et al, (2022), Nature

A protocol to clinically evaluate liquid biopsies as a tool to speed up diagnosis of children and young adults with aggressive infection-related lymphoma in East Africa "(AI-REAL)".

Legason ID. et al, (2022), BMC Cancer, 22

Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors.

Allsup D. et al, (2022), Am J Hematol

Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.

Reijns MAM. et al, (2022), Nature, 602, 623 - 631

TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.

Catherwood MA. et al, (2022), Front Oncol, 12

Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania.

Christopher H. et al, (2021), BMC Genomics, 22

Eleven Cases of Hb J-Paris-I [HBA2: c.38C>A (or HBA1)]: A Stable α Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography.

Khalil MSM. et al, (2021), Hemoglobin, 1 - 3

Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1-2 study.

Eyre TA. et al, (2021), Lancet Haematol

Eight Cases of Hb Winnipeg [HBA2: c.226G>T (or HBA1)]: A Detailed Study.

Khalil MSM. et al, (2021), Hemoglobin, 1 - 3

Management of cardiovascular complications of bruton tyrosine kinase inhibitors.

Tang CPS. et al, (2021), Br J Haematol

TP53 mutations with low variant allele frequency predict short survival in Chronic Lymphocytic Leukemia.

Bomben R. et al, (2021), Clin Cancer Res

Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.

Jobanputra V. et al, (2021), Semin Cancer Biol

Clinical utility of whole-genome sequencing in precision oncology.

Rosenquist R. et al, (2021), Semin Cancer Biol

Load More

1
2
3
4
5
6
7
...
»